PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment

NCT01581541 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

NIH

Sponsor class

Stopped The study closed prematurely due to discontinuation of drug supply.

Conditions

Solid Tumors
Lymphoma

Interventions

DRUG: PU-H71

Sponsor

National Cancer Institute (NCI)